Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Mater Sci Eng C Mater Biol Appl ; 75: 317-334, 2017 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-28415468

RESUMEN

Commercial infusion tubing and blood storage devices (tubing, blood and platelets bags) made of plasticized PVC were analyzed by spectroscopic, chromatographic and microscopic techniques in order to identify and quantify the additives added to the polymer (lubricants, thermal stabilizers, plasticizers) and to put into evidence their blooming onto the surface of the devices. For all the samples, deposits were observed on the surface but with different kinds of morphologies. Ethylene bis amide lubricant and metallic stearate stabilizers were implicated in the formation of these layers. In contact with aqueous media, these insoluble deposits were damaged, suggesting a possible particulate contamination of the infused solutions.


Asunto(s)
Conservación de la Sangre/instrumentación , Cloruro de Polivinilo/química , Conservación de la Sangre/métodos , Humanos , Lubricantes/química , Estearatos/química , Propiedades de Superficie
2.
Org Biomol Chem ; 14(11): 3080-90, 2016 Mar 21.
Artículo en Inglés | MEDLINE | ID: mdl-26891970

RESUMEN

The efficiency of the transfection of a plasmid DNA encoding a galactosidase promoted by a series of pyridinium lipids in mixtures with other cationic lipids and neutral lipids was assessed in CHO-K1 cells. We identify key molecular parameters of the lipids in the mixture - clog P, lipid length, partial molar volume - to predict the morphology of the lipid-DNA lipoplex and then correlate these same parameters with transfection efficiency in an in vitro assay. We define a Transfection Index that provides a linear correlation with normalized transfection efficiency over a series of 90 different lipoplex compositions. We also explore the influence of the same set of molecular parameters on the cytotoxicity of the formulations.


Asunto(s)
ADN/administración & dosificación , Galactosidasas/genética , Lípidos/química , Plásmidos/administración & dosificación , Compuestos de Piridinio/química , Transfección , Animales , Células CHO , Cationes/química , Cationes/toxicidad , Supervivencia Celular/efectos de los fármacos , Cricetulus , ADN/genética , Lípidos/toxicidad , Plásmidos/genética , Compuestos de Piridinio/toxicidad , Transfección/métodos
3.
Eur J Pharm Biopharm ; 96: 396-408, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26386355

RESUMEN

A polymer based material was developed to act as an embolic agent and drug reservoir for the treatment of arteriovenous malformations (AVM) and hyper vascularized solid tumors. The aim was to combine the blocking of blood supply to the target region and the inhibition of the embolization-stimulated angiogenesis. The material is composed of an ethanolic solution of a linear acrylate based copolymer and acrylate calibrated microparticles containing nanospheres loaded with sunitinib, an anti-angiogenic agent. The precipitation of the linear copolymer in aqueous environment after injection through microcatheter results in the formation of an in-situ embolization gel whereas the microparticles serve to increase the cohesive properties of the embolization agent and to form a reservoir from which the sunitinib-loaded nanospheres are released post-embolization. The swollen state of the microparticles in contact with aqueous medium results in the release of the nanospheres out of microparticles macromolecular structure. After the synthesis, the formulation and the characterization of the different components of the material, anti-angiogenic activity was evaluated in vitro using endothelial cells and in vivo using corneal neovascularization model in rabbit. The efficiency of the arterial embolization was tested in vivo in a sheep model. Results proved the feasibility of this new system for vascular embolization in association with an in situ delivery of anti-angiogenic drug. This combination is a promising strategy for the management of arteriovenous malformations and solid tumors.


Asunto(s)
Inhibidores de la Angiogénesis/administración & dosificación , Sistemas de Liberación de Medicamentos , Embolización Terapéutica , Endotelio Vascular/efectos de los fármacos , Indoles/administración & dosificación , Nanosferas/química , Neovascularización Patológica/prevención & control , Pirroles/administración & dosificación , Acrilatos/efectos adversos , Acrilatos/química , Inhibidores de la Angiogénesis/efectos adversos , Inhibidores de la Angiogénesis/farmacología , Inhibidores de la Angiogénesis/uso terapéutico , Animales , Malformaciones Arteriovenosas/tratamiento farmacológico , Materiales Biocompatibles/efectos adversos , Materiales Biocompatibles/química , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Córnea/irrigación sanguínea , Córnea/efectos de los fármacos , Córnea/patología , Preparaciones de Acción Retardada/administración & dosificación , Preparaciones de Acción Retardada/efectos adversos , Preparaciones de Acción Retardada/farmacología , Preparaciones de Acción Retardada/uso terapéutico , Composición de Medicamentos , Sistemas de Liberación de Medicamentos/efectos adversos , Embolización Terapéutica/efectos adversos , Endotelio Vascular/citología , Endotelio Vascular/patología , Geles , Células Endoteliales de la Vena Umbilical Humana/citología , Indoles/efectos adversos , Indoles/farmacología , Indoles/uso terapéutico , Músculos Intercostales/irrigación sanguínea , Músculos Intercostales/efectos de los fármacos , Músculos Intercostales/patología , Nanosferas/efectos adversos , Neovascularización Patológica/patología , Pirroles/efectos adversos , Pirroles/farmacología , Pirroles/uso terapéutico , Conejos , Distribución Aleatoria , Oveja Doméstica , Sunitinib
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...